Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

KINDOS

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 65
  • 0 comments

FDA approve DOXYCYCLINE HYCLATE

Comment Full text

STERISCIENCE

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 50
  • 0 comments

FDA approve THIAMINE HYDROCHLORIDE

Comment Full text

NEXUS

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 66
  • 0 comments

FDA approve CYCLOPHOSPHAMIDE

Comment Full text

TG THERAPEUTICS, INC

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 54
  • 0 comments

FDA approve UBLITUXIMAB-XIIY

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Oct. 31, 2024, 08:50 UTC
  • 56
  • 0 comments

FDA approve LIDOCAINE HYDROCHLORIDE

Comment Full text

PRINSTON PHARMA INC

  • FDA Approval
  • Oct. 30, 2024, 13:22 UTC
  • 63
  • 0 comments

FDA approve BRIVARACETAM

Comment Full text

MSN LABORATORIES PRIVATE LTD

  • FDA Approval
  • Oct. 30, 2024, 13:22 UTC
  • 60
  • 0 comments

FDA approve CABAZITAXEL

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Oct. 30, 2024, 13:10 UTC
  • 61
  • 0 comments

FDA approve PALBOCICLIB

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Oct. 30, 2024, 13:10 UTC
  • 67
  • 0 comments

FDA approve SITAGLIPTIN;METFORMIN HYDROCHLORIDE

Comment Full text

TEVA PHARMS INC

  • FDA Approval
  • Oct. 30, 2024, 13:00 UTC
  • 66
  • 0 comments

FDA approve GLYCEROL PHENYLBUTYRATE

Comment Full text
  • Previous
  • 324
  • 325
  • 326
  • 327
  • 328
  • Next

Search

News categories

  • Technical Exchange News(14648)
  • Event(6229)
  • SEC News(388752)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(237588)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin